Exact Mass: 423.24431620000007

Exact Mass Matches: 423.24431620000007

Found 282 metabolites which its exact mass value is equals to given mass value 423.24431620000007, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

   

47642-02-4

4-Chloro-alpha-[4-[2-(diethylamino)ethoxy]phenyl]-alpha-phenylbenzeneethanol

C26H30ClNO2 (423.196495)


   

Idanpramine

Idanpramine

C24H29N3O4 (423.21579540000005)


A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders

   

Urapidil Hydrochloride

Urapidil Hydrochloride

C20H30ClN5O3 (423.203706)


Urapidil hydrochloride is an orally active α1-adrenoceptor antagonist and 5-HT1A receptor agonist with a pIC50 of 6.13 and 4.38 against α1- and α2-adrenoceptor, respectively. Urapidil hydrochloride shows antihypertensive effect[1][2].

   
   

LysoPE(14:1(9Z)/0:0)

(2-aminoethoxy)[(2R)-2-hydroxy-3-[(9Z)-tetradec-9-enoyloxy]propoxy]phosphinic acid

C19H38NO7P (423.23857680000003)


LysoPE(14:1(9Z)/0:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms. [HMDB] LysoPE(14:1(9Z)/0:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.

   

LysoPE(0:0/14:1(9Z))

(2-aminoethoxy)[(2R)-3-hydroxy-2-[(9Z)-tetradec-9-enoyloxy]propoxy]phosphinic acid

C19H38NO7P (423.23857680000003)


LysoPE(0:0/14:1(9Z)) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms. [HMDB] LysoPE(0:0/14:1(9Z)) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.

   

(6E,9E,12E)-hexadeca-6,9,12-trienedioylcarnitine

3-[(15-Carboxypentadeca-6,9,12-trienoyl)oxy]-4-(trimethylazaniumyl)butanoic acid

C23H37NO6 (423.26207420000003)


(6E,9E,12E)-Hexadeca-6,9,12-trienedioylcarnitine is an acylcarnitine. More specifically, it is an (6E,9E,12E)-hexadeca-6,9,12-trienedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (6E,9E,12E)-Hexadeca-6,9,12-trienedioylcarnitine is therefore classified as a long chain AC. As a long-chain acylcarnitine (6E,9E,12E)-Hexadeca-6,9,12-trienedioylcarnitine is generally formed through esterification with long-chain fatty acids obtained from the diet. The main function of most long-chain acylcarnitines is to ensure long chain fatty acid transport into the mitochondria (PMID: 22804748). Altered levels of long-chain acylcarnitines can serve as useful markers for inherited disorders of long-chain fatty acid metabolism. Carnitine palmitoyltransferase I (CPT I, EC:2.3.1.21) is involved in the synthesis of long-chain acylcarnitines (more than C12) on the mitochondrial outer membrane. Elevated serum/plasma levels of long-chain acylcarnitines are not only markers for incomplete FA oxidation but also are indicators of altered carbohydrate and lipid metabolism. High serum concentrations of long-chain acylcarnitines in the postprandial or fed state are markers of insulin resistance and arise from insulins inability to inhibit CPT-1-dependent fatty acid metabolism in muscles and the heart (PMID: 19073774). Increased intracellular content of long-chain acylcarnitines is thought to serve as a feedback inhibition mechanism of insulin action (PMID: 23258903). In healthy subjects, increased concentrations of insulin effectively inhibits long-chain acylcarnitine production. Several studies have also found increased levels of circulating long-chain acylcarnitines in chronic heart failure patients (PMID: 26796394). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(5E,8E,11E)-Hexadeca-5,8,11-trienedioylcarnitine

3-[(15-carboxypentadeca-5,8,11-trienoyl)oxy]-4-(trimethylazaniumyl)butanoate

C23H37NO6 (423.26207420000003)


(5E,8E,11E)-hexadeca-5,8,11-trienedioylcarnitine is an acylcarnitine. More specifically, it is an (5E,8E,11E)-hexadeca-5,8,11-trienedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (5E,8E,11E)-hexadeca-5,8,11-trienedioylcarnitine is therefore classified as a long chain AC. As a long-chain acylcarnitine (5E,8E,11E)-hexadeca-5,8,11-trienedioylcarnitine is generally formed through esterification with long-chain fatty acids obtained from the diet. The main function of most long-chain acylcarnitines is to ensure long chain fatty acid transport into the mitochondria (PMID: 22804748). Altered levels of long-chain acylcarnitines can serve as useful markers for inherited disorders of long-chain fatty acid metabolism. Carnitine palmitoyltransferase I (CPT I, EC:2.3.1.21) is involved in the synthesis of long-chain acylcarnitines (more than C12) on the mitochondrial outer membrane. Elevated serum/plasma levels of long-chain acylcarnitines are not only markers for incomplete FA oxidation but also are indicators of altered carbohydrate and lipid metabolism. High serum concentrations of long-chain acylcarnitines in the postprandial or fed state are markers of insulin resistance and arise from insulins inability to inhibit CPT-1-dependent fatty acid metabolism in muscles and the heart (PMID: 19073774). Increased intracellular content of long-chain acylcarnitines is thought to serve as a feedback inhibition mechanism of insulin action (PMID: 23258903). In healthy subjects, increased concentrations of insulin effectively inhibits long-chain acylcarnitine production. Several studies have also found increased levels of circulating long-chain acylcarnitines in chronic heart failure patients (PMID: 26796394). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(2Z,6Z,10Z)-Hexadeca-2,6,10-trienedioylcarnitine

3-[(15-carboxypentadeca-2,6,10-trienoyl)oxy]-4-(trimethylazaniumyl)butanoate

C23H37NO6 (423.26207420000003)


(2Z,6Z,10Z)-hexadeca-2,6,10-trienedioylcarnitine is an acylcarnitine. More specifically, it is an (2Z,6Z,10Z)-hexadeca-2,6,10-trienedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (2Z,6Z,10Z)-hexadeca-2,6,10-trienedioylcarnitine is therefore classified as a long chain AC. As a long-chain acylcarnitine (2Z,6Z,10Z)-hexadeca-2,6,10-trienedioylcarnitine is generally formed through esterification with long-chain fatty acids obtained from the diet. The main function of most long-chain acylcarnitines is to ensure long chain fatty acid transport into the mitochondria (PMID: 22804748). Altered levels of long-chain acylcarnitines can serve as useful markers for inherited disorders of long-chain fatty acid metabolism. Carnitine palmitoyltransferase I (CPT I, EC:2.3.1.21) is involved in the synthesis of long-chain acylcarnitines (more than C12) on the mitochondrial outer membrane. Elevated serum/plasma levels of long-chain acylcarnitines are not only markers for incomplete FA oxidation but also are indicators of altered carbohydrate and lipid metabolism. High serum concentrations of long-chain acylcarnitines in the postprandial or fed state are markers of insulin resistance and arise from insulins inability to inhibit CPT-1-dependent fatty acid metabolism in muscles and the heart (PMID: 19073774). Increased intracellular content of long-chain acylcarnitines is thought to serve as a feedback inhibition mechanism of insulin action (PMID: 23258903). In healthy subjects, increased concentrations of insulin effectively inhibits long-chain acylcarnitine production. Several studies have also found increased levels of circulating long-chain acylcarnitines in chronic heart failure patients (PMID: 26796394). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(2Z,5Z,9Z)-Hexadeca-2,5,9-trienedioylcarnitine

3-[(15-carboxypentadeca-2,5,9-trienoyl)oxy]-4-(trimethylazaniumyl)butanoate

C23H37NO6 (423.26207420000003)


(2Z,5Z,9Z)-hexadeca-2,5,9-trienedioylcarnitine is an acylcarnitine. More specifically, it is an (2Z,5Z,9Z)-hexadeca-2,5,9-trienedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (2Z,5Z,9Z)-hexadeca-2,5,9-trienedioylcarnitine is therefore classified as a long chain AC. As a long-chain acylcarnitine (2Z,5Z,9Z)-hexadeca-2,5,9-trienedioylcarnitine is generally formed through esterification with long-chain fatty acids obtained from the diet. The main function of most long-chain acylcarnitines is to ensure long chain fatty acid transport into the mitochondria (PMID: 22804748). Altered levels of long-chain acylcarnitines can serve as useful markers for inherited disorders of long-chain fatty acid metabolism. Carnitine palmitoyltransferase I (CPT I, EC:2.3.1.21) is involved in the synthesis of long-chain acylcarnitines (more than C12) on the mitochondrial outer membrane. Elevated serum/plasma levels of long-chain acylcarnitines are not only markers for incomplete FA oxidation but also are indicators of altered carbohydrate and lipid metabolism. High serum concentrations of long-chain acylcarnitines in the postprandial or fed state are markers of insulin resistance and arise from insulins inability to inhibit CPT-1-dependent fatty acid metabolism in muscles and the heart (PMID: 19073774). Increased intracellular content of long-chain acylcarnitines is thought to serve as a feedback inhibition mechanism of insulin action (PMID: 23258903). In healthy subjects, increased concentrations of insulin effectively inhibits long-chain acylcarnitine production. Several studies have also found increased levels of circulating long-chain acylcarnitines in chronic heart failure patients (PMID: 26796394). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(3E,9E,12E)-Hexadeca-3,9,12-trienedioylcarnitine

3-[(15-carboxypentadeca-3,9,12-trienoyl)oxy]-4-(trimethylazaniumyl)butanoate

C23H37NO6 (423.26207420000003)


(3E,9E,12E)-hexadeca-3,9,12-trienedioylcarnitine is an acylcarnitine. More specifically, it is an (3E,9E,12E)-hexadeca-3,9,12-trienedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (3E,9E,12E)-hexadeca-3,9,12-trienedioylcarnitine is therefore classified as a long chain AC. As a long-chain acylcarnitine (3E,9E,12E)-hexadeca-3,9,12-trienedioylcarnitine is generally formed through esterification with long-chain fatty acids obtained from the diet. The main function of most long-chain acylcarnitines is to ensure long chain fatty acid transport into the mitochondria (PMID: 22804748). Altered levels of long-chain acylcarnitines can serve as useful markers for inherited disorders of long-chain fatty acid metabolism. Carnitine palmitoyltransferase I (CPT I, EC:2.3.1.21) is involved in the synthesis of long-chain acylcarnitines (more than C12) on the mitochondrial outer membrane. Elevated serum/plasma levels of long-chain acylcarnitines are not only markers for incomplete FA oxidation but also are indicators of altered carbohydrate and lipid metabolism. High serum concentrations of long-chain acylcarnitines in the postprandial or fed state are markers of insulin resistance and arise from insulins inability to inhibit CPT-1-dependent fatty acid metabolism in muscles and the heart (PMID: 19073774). Increased intracellular content of long-chain acylcarnitines is thought to serve as a feedback inhibition mechanism of insulin action (PMID: 23258903). In healthy subjects, increased concentrations of insulin effectively inhibits long-chain acylcarnitine production. Several studies have also found increased levels of circulating long-chain acylcarnitines in chronic heart failure patients (PMID: 26796394). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-

5-{5-[(piperazin-1-yl)methyl]-1,3,4-oxadiazol-2-yl}-N4-propyl-N2-[2-(pyridin-4-yl)ethyl]pyrimidine-2,4-diamine

C21H29N9O (423.2494944)


   
   
   
   

Adipamide, 4-amino-2,3-dihydroxy-N-(1-(8-hydroxy-1-oxo-3,4-dihydro-1H-2-benzopyran-3-yl)-3-methylbutyl)-

Adipamide, 4-amino-2,3-dihydroxy-N-(1-(8-hydroxy-1-oxo-3,4-dihydro-1H-2-benzopyran-3-yl)-3-methylbutyl)-

C20H29N3O7 (423.2005404)


   

Aconitane-1,7,8,14-tetrol, 20-ethyl-16-methoxy-4-(methoxymethyl)-, (1alpha,14alpha,16beta)-

Aconitane-1,7,8,14-tetrol, 20-ethyl-16-methoxy-4-(methoxymethyl)-, (1alpha,14alpha,16beta)-

C23H37NO6 (423.26207420000003)


   

14-Demethyltuguaconitine

(+)-14-Demethyltuguaconitine

C22H33NO7 (423.22569080000005)


   

senbusine A

senbusine A

C23H37NO6 (423.26207420000003)


A diterpene alkaloid with formula C23H37NO6 that is isolated from several Aconitum species.

   
   
   

([1,2]Sa,32S)-16,26-dihydroxy-25-methoxy-(32rH,34tH,39ac)-3-octahydro-4-oxa-1(1,3),2(1,2)-dibenzena-3(4,2)-quinolizina-cycloheptaphan-5-one|2,6-dihydroxy-5-methoxy-13,14-dihydro-(10alpha)-lythran-12-one|Dihydroverticillatin|Dihydroverticillatine|verticillatine

([1,2]Sa,32S)-16,26-dihydroxy-25-methoxy-(32rH,34tH,39ac)-3-octahydro-4-oxa-1(1,3),2(1,2)-dibenzena-3(4,2)-quinolizina-cycloheptaphan-5-one|2,6-dihydroxy-5-methoxy-13,14-dihydro-(10alpha)-lythran-12-one|Dihydroverticillatin|Dihydroverticillatine|verticillatine

C25H29NO5 (423.20456240000004)


   
   

6beta,14alpha,16beta-trimethoxy-1alpha,4beta,8beta-trihydroxy-N-ethylaconitane|akiramidine

6beta,14alpha,16beta-trimethoxy-1alpha,4beta,8beta-trihydroxy-N-ethylaconitane|akiramidine

C23H37NO6 (423.26207420000003)


   
   

(12S)-46-hydroxy-23-methoxy-(12rH,14tH,19ac)-1-octahydro-3,8-dioxa-2(1,2),4(1,3)-dibenzena-1(4,2)-quinolizina-cyclooctaphan-7-one|Lagerin

(12S)-46-hydroxy-23-methoxy-(12rH,14tH,19ac)-1-octahydro-3,8-dioxa-2(1,2),4(1,3)-dibenzena-1(4,2)-quinolizina-cyclooctaphan-7-one|Lagerin

C25H29NO5 (423.20456240000004)


   

Antibiotic AI 77A|B,HCl-Antibiotic AI 77A

Antibiotic AI 77A|B,HCl-Antibiotic AI 77A

C20H29N3O7 (423.2005404)


   
   
   
   
   
   
   

L-Valyl-L-amiclenomycyl-L-glutamine|Valylamiclenomycylglutamine

L-Valyl-L-amiclenomycyl-L-glutamine|Valylamiclenomycylglutamine

C20H33N5O5 (423.24815680000006)


   
   
   
   

(3Z,6S)-3-{{2-(1,1-dimethylprop-2-en-1-yl)-7-{[3-(hydroxymethyl)-3-methyloxiran-2-yl]methyl}-1H-indol-3-yl}methylidene}-6-methylpiperazine-2,5-dione|variecolorin N

(3Z,6S)-3-{{2-(1,1-dimethylprop-2-en-1-yl)-7-{[3-(hydroxymethyl)-3-methyloxiran-2-yl]methyl}-1H-indol-3-yl}methylidene}-6-methylpiperazine-2,5-dione|variecolorin N

C24H29N3O4 (423.21579540000005)


   
   
   
   

N-demethylteleocidin A1|N13-desmethylteleocidin A-1

N-demethylteleocidin A1|N13-desmethylteleocidin A-1

C26H37N3O2 (423.2885622)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

tyrosylasparagyllysine

tyrosylasparagyllysine

C19H29N5O6 (423.2117734)


   
   

1,N2-Trans-4-hydroxy-2-nonenal-deoxyguanosine

1,N2-Trans-4-hydroxy-2-nonenal-deoxyguanosine

C19H29N5O6 (423.2117734)


   

RO 40-5966 (Methylmibefradil Metabolite)

RO 40-5966 (Methylmibefradil Metabolite)

C26H34FN3O (423.2685766)


   

Gly Gly Lys Tyr

(2S)-2-[(2S)-6-amino-2-[2-(2-aminoacetamido)acetamido]hexanamido]-3-(4-hydroxyphenyl)propanoic acid

C19H29N5O6 (423.2117734)


   

Gly Gly Tyr Lys

(2S)-6-amino-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]-3-(4-hydroxyphenyl)propanamido]hexanoic acid

C19H29N5O6 (423.2117734)


   

Gly Lys Gly Tyr

(2S)-2-{2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]acetamido}-3-(4-hydroxyphenyl)propanoic acid

C19H29N5O6 (423.2117734)


   

Gly Lys Tyr Gly

2-[(2S)-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]-3-(4-hydroxyphenyl)propanamido]acetic acid

C19H29N5O6 (423.2117734)


   

Gly Tyr Gly Lys

(2S)-6-amino-2-{2-[(2S)-2-(2-aminoacetamido)-3-(4-hydroxyphenyl)propanamido]acetamido}hexanoic acid

C19H29N5O6 (423.2117734)


   

Gly Tyr Lys Gly

2-[(2S)-6-amino-2-[(2S)-2-(2-aminoacetamido)-3-(4-hydroxyphenyl)propanamido]hexanamido]acetic acid

C19H29N5O6 (423.2117734)


   
   
   

Lys Gly Gly Tyr

(2S)-2-(2-{2-[(2S)-2,6-diaminohexanamido]acetamido}acetamido)-3-(4-hydroxyphenyl)propanoic acid

C19H29N5O6 (423.2117734)


   

Lys Gly Tyr Gly

2-[(2S)-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}-3-(4-hydroxyphenyl)propanamido]acetic acid

C19H29N5O6 (423.2117734)


   

Lys Tyr Gly Gly

2-{2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(4-hydroxyphenyl)propanamido]acetamido}acetic acid

C19H29N5O6 (423.2117734)


   
   

Asn Pro Pro Pro

(2S)-1-{[(2S)-1-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid

C19H29N5O6 (423.2117734)


   

Pro Asn Pro Pro

(2S)-1-{[(2S)-1-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid

C19H29N5O6 (423.2117734)


   

Pro Pro Asn Pro

(2S)-1-[(2S)-3-carbamoyl-2-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}propanoyl]pyrrolidine-2-carboxylic acid

C19H29N5O6 (423.2117734)


   

Pro Pro Pro Asn

(2S)-3-carbamoyl-2-{[(2S)-1-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}propanoic acid

C19H29N5O6 (423.2117734)


   
   
   
   
   
   

Tyr Gly Gly Lys

(2S)-6-amino-2-(2-{2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]acetamido}acetamido)hexanoic acid

C19H29N5O6 (423.2117734)


   

Tyr Gly Lys Gly

2-[(2S)-6-amino-2-{2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]acetamido}hexanamido]acetic acid

C19H29N5O6 (423.2117734)


   

Tyr Lys Gly Gly

2-{2-[(2S)-6-amino-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]hexanamido]acetamido}acetic acid

C19H29N5O6 (423.2117734)


   

N-Palmitoyl-L-serine phosphoric acid

N-Palmitoyl-L-serine phosphoric acid

C19H38NO7P (423.23857680000003)


   

thio-Miltefosine

1-hexadecyl-thio-phosphorylcholine

C21H46NO3PS (423.2935856000001)


   

LPE(14:1)

1-Myristoleoyl-2-hydroxy-sn-glycero-3-phosphoethanolamine

C19H38NO7P (423.23857680000003)


   

PE(14:1(9Z)/0:0)

1-(9Z-tetradecenoyl)-glycero-3-phosphoethanolamine

C19H38NO7P (423.23857680000003)


   

LPE 14:1

2-(9Z-tetradecenoyl)-sn-glycero-3-phosphoethanolamine

C19H38NO7P (423.23857680000003)


   

N,N-BIS(2-HYDROXYETHYL)-N-METHYLHEXADECAN-1-AMINIUM BROMIDE

N,N-BIS(2-HYDROXYETHYL)-N-METHYLHEXADECAN-1-AMINIUM BROMIDE

C21H46BrNO2 (423.2711716)


   

(3R,4S)-1-benzoyl-4-phenyl-3-tri(propan-2-yl)silyloxyazetidin-2-one

(3R,4S)-1-benzoyl-4-phenyl-3-tri(propan-2-yl)silyloxyazetidin-2-one

C25H33NO3Si (423.2229588000001)


   

8H-Indeno[1,2-d]oxazole, 2-[2,2-bis[(4S)-4,5-dihydro-4-(1-methylethyl)-2-oxazolyl]propyl]-3a,8a-dihydro-, (3aS,8aR)

8H-Indeno[1,2-d]oxazole, 2-[2,2-bis[(4S)-4,5-dihydro-4-(1-methylethyl)-2-oxazolyl]propyl]-3a,8a-dihydro-, (3aS,8aR)

C25H33N3O3 (423.2521788)


   

Tocamphyl

2-(2-hydroxyethylamino)ethanol,2,2,3-trimethyl-3-[1-(4-methylphenyl)ethoxycarbonyl]cyclopentane-1-carboxylic acid

C23H37NO6 (423.26207420000003)


   

4-N,N-DIPHENYLAMINO-B-PHENYLSTILBENE

4-N,N-DIPHENYLAMINO-B-PHENYLSTILBENE

C32H25N (423.198689)


   

p-[(5-cyano-1,6-dihydro-2-hydroxy-1,4-dimethyl-6-oxo-3-pyridyl)azo]-N-(2-ethylhexyl)benzamide

p-[(5-cyano-1,6-dihydro-2-hydroxy-1,4-dimethyl-6-oxo-3-pyridyl)azo]-N-(2-ethylhexyl)benzamide

C23H29N5O3 (423.2270284)


   
   

n-2-nitrophenylsulfenyl-l-alanine dicyclohexylammonium salt

n-2-nitrophenylsulfenyl-l-alanine dicyclohexylammonium salt

C21H33N3O4S (423.2191658000001)


   

(3R,4R)-4-(4-(benzyloxy)phenyl)-1-((R)-1-phenylethyl)piperidin-3-ol hydrochloride

(3R,4R)-4-(4-(benzyloxy)phenyl)-1-((R)-1-phenylethyl)piperidin-3-ol hydrochloride

C26H30ClNO2 (423.196495)


   

methyl 2-methylprop-2-enoate,2-methylpropyl prop-2-enoate,oxiran-2-ylmethyl 2-methylprop-2-enoate,prop-2-enenitrile

methyl 2-methylprop-2-enoate,2-methylpropyl prop-2-enoate,oxiran-2-ylmethyl 2-methylprop-2-enoate,prop-2-enenitrile

C22H33NO7 (423.22569080000005)


   

2-[(2S,4R)-1-(9H-fluoren-9-ylmethoxycarbonyl)-4-[(2-methylpropan-2-yl)oxy]pyrrolidin-2-yl]acetic acid

2-[(2S,4R)-1-(9H-fluoren-9-ylmethoxycarbonyl)-4-[(2-methylpropan-2-yl)oxy]pyrrolidin-2-yl]acetic acid

C25H29NO5 (423.20456240000004)


   
   

Cyprenorphine

Cyprenorphine

C26H33NO4 (423.2409458000001)


D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist

   

1-Cyclohexyl-3-(2-morpholinoethyl)carbodiimide metho-p-toluenesulfonate

1-Cyclohexyl-3-(2-morpholinoethyl)carbodiimide metho-p-toluenesulfonate

C21H33N3O4S (423.2191658000001)


   

2-(dicyclohexylphosphino)-6-methoxy-N,N-dimethylbiphenyl-2-amine

2-(dicyclohexylphosphino)-6-methoxy-N,N-dimethylbiphenyl-2-amine

C27H38NOP (423.2690868)


   
   

2-O-benzyl 1-O-tert-butyl (2S,4R)-4-[(4-methylphenyl)methyl]-5-oxopyrrolidine-1,2-dicarboxylate

2-O-benzyl 1-O-tert-butyl (2S,4R)-4-[(4-methylphenyl)methyl]-5-oxopyrrolidine-1,2-dicarboxylate

C25H29NO5 (423.20456240000004)


   

Phosphonic acid 2-dodecanoylamino-hexyl ester propyl ester

Phosphonic acid 2-dodecanoylamino-hexyl ester propyl ester

C20H42NO6P (423.27496020000007)


   

1-{[(2S)-3-(diethylamino)-2-hydroxypropyl]amino}-4-({[(2S)-oxiran-2-yl]methyl}amino)anthracene-9,10-dione

1-{[(2S)-3-(diethylamino)-2-hydroxypropyl]amino}-4-({[(2S)-oxiran-2-yl]methyl}amino)anthracene-9,10-dione

C24H29N3O4 (423.21579540000005)


   

N-butyl-3-{[6-(9H-purin-6-ylamino)hexanoyl]amino}benzamide

N-butyl-3-{[6-(9H-purin-6-ylamino)hexanoyl]amino}benzamide

C22H29N7O2 (423.2382614)


   

4-{[1-Methyl-5-(2-methyl-benzoimidazol-1-ylmethyl)-1H-benzoimidazol-2-ylmethyl]-amino}-benzamidine

4-{[1-Methyl-5-(2-methyl-benzoimidazol-1-ylmethyl)-1H-benzoimidazol-2-ylmethyl]-amino}-benzamidine

C25H25N7 (423.217133)


   

5-S-[(1E)-6-amino-1-(2-aminoethylidene)hexyl]-5-thioadenosine

5-S-[(1E)-6-amino-1-(2-aminoethylidene)hexyl]-5-thioadenosine

C18H29N7O3S (423.2052484000001)


   

4-amino-1-(4-{[(3S)-3-ammonio-5-{[ammonio(imino)methyl](methyl)amino}pentanoyl]amino}-2,3,4-trideoxy-beta-D-erythro-hex-2-enopyranosyluronosyl)pyrimidin-2(1H)-one

4-amino-1-(4-{[(3S)-3-ammonio-5-{[ammonio(imino)methyl](methyl)amino}pentanoyl]amino}-2,3,4-trideoxy-beta-D-erythro-hex-2-enopyranosyluronosyl)pyrimidin-2(1H)-one

C17H27N8O5+ (423.2104312)


   
   
   
   
   

1-formyl-3-methoxy-10a-methyl-7-(4-methylpent-3-enyl)-9,10-dioxo-4-propan-2-yl-8,8a-dihydro-5H-anthracen-2-olate

1-formyl-3-methoxy-10a-methyl-7-(4-methylpent-3-enyl)-9,10-dioxo-4-propan-2-yl-8,8a-dihydro-5H-anthracen-2-olate

C26H31O5- (423.2171376)


   

(3R,5R)-7-[(1S,2S,6R,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoate

(3R,5R)-7-[(1S,2S,6R,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoate

C23H35O7- (423.238266)


   

a 1-acyl-sn-glycero-3-phosphoethanolamine (n-C14:1)

a 1-acyl-sn-glycero-3-phosphoethanolamine (n-C14:1)

C19H38NO7P (423.23857680000003)


   

a 2-acyl-sn-glycero-3-phosphoethanolamine (n-C14:1)

a 2-acyl-sn-glycero-3-phosphoethanolamine (n-C14:1)

C19H38NO7P (423.23857680000003)


   

[(3S)-3-amino-5-[[(2S,3S,6R)-6-(4-amino-2-oxopyrimidin-1-yl)-2-carboxy-3,6-dihydro-2H-pyran-3-yl]amino]-5-oxopentyl]-(diaminomethylidene)-methylazanium

[(3S)-3-amino-5-[[(2S,3S,6R)-6-(4-amino-2-oxopyrimidin-1-yl)-2-carboxy-3,6-dihydro-2H-pyran-3-yl]amino]-5-oxopentyl]-(diaminomethylidene)-methylazanium

C17H27N8O5+ (423.2104312)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] tetradec-7-enoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] tetradec-7-enoate

C19H38NO7P (423.23857680000003)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hydroxypropan-2-yl] (E)-tetradec-7-enoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hydroxypropan-2-yl] (E)-tetradec-7-enoate

C19H38NO7P (423.23857680000003)


   

(2Z,5Z,9Z)-Hexadeca-2,5,9-trienedioylcarnitine

(2Z,5Z,9Z)-Hexadeca-2,5,9-trienedioylcarnitine

C23H37NO6 (423.26207420000003)


   

(6E,9E,12E)-hexadeca-6,9,12-trienedioylcarnitine

(6E,9E,12E)-hexadeca-6,9,12-trienedioylcarnitine

C23H37NO6 (423.26207420000003)


   

(5E,8E,11E)-Hexadeca-5,8,11-trienedioylcarnitine

(5E,8E,11E)-Hexadeca-5,8,11-trienedioylcarnitine

C23H37NO6 (423.26207420000003)


   

(2Z,6Z,10Z)-Hexadeca-2,6,10-trienedioylcarnitine

(2Z,6Z,10Z)-Hexadeca-2,6,10-trienedioylcarnitine

C23H37NO6 (423.26207420000003)


   

(3E,9E,12E)-Hexadeca-3,9,12-trienedioylcarnitine

(3E,9E,12E)-Hexadeca-3,9,12-trienedioylcarnitine

C23H37NO6 (423.26207420000003)


   

3beta-(2-Diethylaminoethoxy)androst-5-en-17-one hydrochloride

3beta-(2-Diethylaminoethoxy)androst-5-en-17-one hydrochloride

C25H42ClNO2 (423.29039020000005)


D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents > D000924 - Anticholesteremic Agents D009676 - Noxae > D000963 - Antimetabolites D004791 - Enzyme Inhibitors

   

Pravachol

Pravachol

C23H35O7- (423.238266)


D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents > D000924 - Anticholesteremic Agents D004791 - Enzyme Inhibitors > D019161 - Hydroxymethylglutaryl-CoA Reductase Inhibitors D009676 - Noxae > D000963 - Antimetabolites

   

Carbamic acid, [(1S)-1-[[[4-(dimethylamino)-1-(fluoroacetyl)-4-oxobutyl]amino]carbonyl]-2-methylpropyl]-, phenylmethyl ester

Carbamic acid, [(1S)-1-[[[4-(dimethylamino)-1-(fluoroacetyl)-4-oxobutyl]amino]carbonyl]-2-methylpropyl]-, phenylmethyl ester

C21H30FN3O5 (423.2169382)


   
   

3-O-{4,6-dideoxy-4-[(3-hydroxy-3-methylbutanoyl)amino]-2-O-methyl-beta-D-glucopyranosyl}-alpha-L-rhamnopyranose

3-O-{4,6-dideoxy-4-[(3-hydroxy-3-methylbutanoyl)amino]-2-O-methyl-beta-D-glucopyranosyl}-alpha-L-rhamnopyranose

C18H33NO10 (423.2104358)


   

4-butoxy-N-[4-[4-(2-methyl-1-oxopropyl)-1-piperazinyl]phenyl]benzamide

4-butoxy-N-[4-[4-(2-methyl-1-oxopropyl)-1-piperazinyl]phenyl]benzamide

C25H33N3O3 (423.2521788)


   

1,5-dimethyl-4-oxo-N-[3-(4-propyl-1-piperazinyl)propyl]-2-pyrrolo[3,2-c]quinolinecarboxamide

1,5-dimethyl-4-oxo-N-[3-(4-propyl-1-piperazinyl)propyl]-2-pyrrolo[3,2-c]quinolinecarboxamide

C24H33N5O2 (423.26341180000003)


   

[3-(4-Methylphenyl)-1-phenyl-4-pyrazolyl]-[4-(2-pyridinyl)-1-piperazinyl]methanone

[3-(4-Methylphenyl)-1-phenyl-4-pyrazolyl]-[4-(2-pyridinyl)-1-piperazinyl]methanone

C26H25N5O (423.2059)


   

3-(3,4-Dimethoxyphenyl)-7-hydroxy-2-methyl-8-[(2-methyl-1-piperidinyl)methyl]-1-benzopyran-4-one

3-(3,4-Dimethoxyphenyl)-7-hydroxy-2-methyl-8-[(2-methyl-1-piperidinyl)methyl]-1-benzopyran-4-one

C25H29NO5 (423.20456240000004)


   

20-Ethyl-16beta-methoxy-4-(methoxymethyl)aconitane-1alpha,6alpha,8,14alpha-tetrol

20-Ethyl-16beta-methoxy-4-(methoxymethyl)aconitane-1alpha,6alpha,8,14alpha-tetrol

C23H37NO6 (423.26207420000003)


   
   
   
   

4,6-dideoxy-4-(2-methoxypropionamido)-3-C,2-O-dimethyl-L-mannopyranosyl-(1->3)-L-fucopyranose

4,6-dideoxy-4-(2-methoxypropionamido)-3-C,2-O-dimethyl-L-mannopyranosyl-(1->3)-L-fucopyranose

C18H33NO10 (423.2104358)


A disaccharide consisting of N-(2-methoxypropionyl)kansosamine linked via a glycosidic bond (of unspecified configuration) to O-3 of L-fucose.

   

6-deoxy-3-O-{4,6-dideoxy-4-[(2-methoxypropanoyl)amino]-3-C-methyl-2-O-methyl-L-mannopyranosyl}-L-galactopyranose

6-deoxy-3-O-{4,6-dideoxy-4-[(2-methoxypropanoyl)amino]-3-C-methyl-2-O-methyl-L-mannopyranosyl}-L-galactopyranose

C18H33NO10 (423.2104358)


   

N-[(3-fluorophenyl)methyl]-2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]acetamide

N-[(3-fluorophenyl)methyl]-2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]acetamide

C21H30FN3O5 (423.2169382)


   

(1R,9S,10S,11S)-N-(cyclohexylmethyl)-10-(hydroxymethyl)-6-oxo-5-pyrimidin-5-yl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide

(1R,9S,10S,11S)-N-(cyclohexylmethyl)-10-(hydroxymethyl)-6-oxo-5-pyrimidin-5-yl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide

C23H29N5O3 (423.2270284)


   

(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-8-[2-(3-methoxyphenyl)ethynyl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-8-[2-(3-methoxyphenyl)ethynyl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C24H29N3O4 (423.21579540000005)


   

(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-8-[2-(3-methoxyphenyl)ethynyl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-8-[2-(3-methoxyphenyl)ethynyl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C24H29N3O4 (423.21579540000005)


   

(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-8-[2-(3-methoxyphenyl)ethynyl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-8-[2-(3-methoxyphenyl)ethynyl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C24H29N3O4 (423.21579540000005)


   

(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-8-[2-(3-methoxyphenyl)ethynyl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-8-[2-(3-methoxyphenyl)ethynyl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C24H29N3O4 (423.21579540000005)


   

N-[(3-fluorophenyl)methyl]-2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]acetamide

N-[(3-fluorophenyl)methyl]-2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]acetamide

C21H30FN3O5 (423.2169382)


   

(1S,9R,10R,11R)-N-(cyclohexylmethyl)-10-(hydroxymethyl)-6-oxo-5-pyrimidin-5-yl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide

(1S,9R,10R,11R)-N-(cyclohexylmethyl)-10-(hydroxymethyl)-6-oxo-5-pyrimidin-5-yl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide

C23H29N5O3 (423.2270284)


   

(1S,9R,10R,11R)-10-(hydroxymethyl)-11-(4-methylpiperazine-1-carbonyl)-12-(pyridin-4-ylmethyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one

(1S,9R,10R,11R)-10-(hydroxymethyl)-11-(4-methylpiperazine-1-carbonyl)-12-(pyridin-4-ylmethyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one

C23H29N5O3 (423.2270284)


   

(2S)-2-[(4S,5S)-5-[(dimethylamino)methyl]-8-[3-(dimethylamino)prop-1-ynyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol

(2S)-2-[(4S,5S)-5-[(dimethylamino)methyl]-8-[3-(dimethylamino)prop-1-ynyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol

C21H33N3O4S (423.2191658000001)


   

N-[(3-fluorophenyl)methyl]-2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]acetamide

N-[(3-fluorophenyl)methyl]-2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]acetamide

C21H30FN3O5 (423.2169382)


   

N-[(3-fluorophenyl)methyl]-2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]acetamide

N-[(3-fluorophenyl)methyl]-2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]acetamide

C21H30FN3O5 (423.2169382)


   

N-[(3-fluorophenyl)methyl]-2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]acetamide

N-[(3-fluorophenyl)methyl]-2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]acetamide

C21H30FN3O5 (423.2169382)


   

2-fluoro-N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-[[2-(4-morpholinyl)-1-oxoethyl]amino]ethyl]-3-oxanyl]benzamide

2-fluoro-N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-[[2-(4-morpholinyl)-1-oxoethyl]amino]ethyl]-3-oxanyl]benzamide

C21H30FN3O5 (423.2169382)


   

2-fluoro-N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-[[2-(4-morpholinyl)-1-oxoethyl]amino]ethyl]-3-oxanyl]benzamide

2-fluoro-N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-[[2-(4-morpholinyl)-1-oxoethyl]amino]ethyl]-3-oxanyl]benzamide

C21H30FN3O5 (423.2169382)


   

2-fluoro-N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-[[2-(4-morpholinyl)-1-oxoethyl]amino]ethyl]-3-oxanyl]benzamide

2-fluoro-N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-[[2-(4-morpholinyl)-1-oxoethyl]amino]ethyl]-3-oxanyl]benzamide

C21H30FN3O5 (423.2169382)


   

(1R,9S,10S,11S)-10-(hydroxymethyl)-11-(4-methylpiperazine-1-carbonyl)-12-(pyridin-4-ylmethyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one

(1R,9S,10S,11S)-10-(hydroxymethyl)-11-(4-methylpiperazine-1-carbonyl)-12-(pyridin-4-ylmethyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one

C23H29N5O3 (423.2270284)


   

3-[(3aR,4S,9bR)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]-N,N-dimethylbenzamide

3-[(3aR,4S,9bR)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]-N,N-dimethylbenzamide

C24H29N3O4 (423.21579540000005)


   

3-[(3aR,4R,9bR)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]-N,N-dimethylbenzamide

3-[(3aR,4R,9bR)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]-N,N-dimethylbenzamide

C24H29N3O4 (423.21579540000005)


   

(8R,9S,10S)-N-(4-fluorophenyl)-10-(hydroxymethyl)-9-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazabicyclo[6.2.0]decane-6-carboxamide

(8R,9S,10S)-N-(4-fluorophenyl)-10-(hydroxymethyl)-9-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazabicyclo[6.2.0]decane-6-carboxamide

C25H30FN3O2 (423.2321932)


   

(8R,9R,10R)-N-(4-fluorophenyl)-10-(hydroxymethyl)-9-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazabicyclo[6.2.0]decane-6-carboxamide

(8R,9R,10R)-N-(4-fluorophenyl)-10-(hydroxymethyl)-9-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazabicyclo[6.2.0]decane-6-carboxamide

C25H30FN3O2 (423.2321932)


   

(8S,9R,10S)-N-(4-fluorophenyl)-10-(hydroxymethyl)-9-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazabicyclo[6.2.0]decane-6-carboxamide

(8S,9R,10S)-N-(4-fluorophenyl)-10-(hydroxymethyl)-9-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazabicyclo[6.2.0]decane-6-carboxamide

C25H30FN3O2 (423.2321932)


   

cyclopentyl-[(8R,9S,10S)-9-[4-[3-(dimethylamino)prop-1-ynyl]phenyl]-10-(hydroxymethyl)-1,6-diazabicyclo[6.2.0]decan-6-yl]methanone

cyclopentyl-[(8R,9S,10S)-9-[4-[3-(dimethylamino)prop-1-ynyl]phenyl]-10-(hydroxymethyl)-1,6-diazabicyclo[6.2.0]decan-6-yl]methanone

C26H37N3O2 (423.2885622)


   

[(1R)-2-[(4-fluorophenyl)methyl]-7-methoxy-1-methyl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol

[(1R)-2-[(4-fluorophenyl)methyl]-7-methoxy-1-methyl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol

C25H30FN3O2 (423.2321932)


   

(6S,7S,8S)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-propyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

(6S,7S,8S)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-propyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C25H33N3O3 (423.2521788)


   

(6R,7R,8S)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-propyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

(6R,7R,8S)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-propyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C25H33N3O3 (423.2521788)


   

(6S,7S,8R)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-propyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

(6S,7S,8R)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-propyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C25H33N3O3 (423.2521788)


   

2-cyclopropyl-1-[(1R)-2-(cyclopropylmethyl)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]ethanone

2-cyclopropyl-1-[(1R)-2-(cyclopropylmethyl)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]ethanone

C25H33N3O3 (423.2521788)


   

2-(4,4-Diphenyl-1-piperidinobuta-1,3-dienyl)phenyl acetate

2-(4,4-Diphenyl-1-piperidinobuta-1,3-dienyl)phenyl acetate

C29H29NO2 (423.2198174)


   

N-[(3-fluorophenyl)methyl]-2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]acetamide

N-[(3-fluorophenyl)methyl]-2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]acetamide

C21H30FN3O5 (423.2169382)


   

N-[(3-fluorophenyl)methyl]-2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]acetamide

N-[(3-fluorophenyl)methyl]-2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]acetamide

C21H30FN3O5 (423.2169382)


   

N-[(3-fluorophenyl)methyl]-2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]acetamide

N-[(3-fluorophenyl)methyl]-2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]acetamide

C21H30FN3O5 (423.2169382)


   

2-fluoro-N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-[[2-(4-morpholinyl)-1-oxoethyl]amino]ethyl]-3-oxanyl]benzamide

2-fluoro-N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-[[2-(4-morpholinyl)-1-oxoethyl]amino]ethyl]-3-oxanyl]benzamide

C21H30FN3O5 (423.2169382)


   

2-fluoro-N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-[[2-(4-morpholinyl)-1-oxoethyl]amino]ethyl]-3-oxanyl]benzamide

2-fluoro-N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-[[2-(4-morpholinyl)-1-oxoethyl]amino]ethyl]-3-oxanyl]benzamide

C21H30FN3O5 (423.2169382)


   

2-fluoro-N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-[[2-(4-morpholinyl)-1-oxoethyl]amino]ethyl]-3-oxanyl]benzamide

2-fluoro-N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-[[2-(4-morpholinyl)-1-oxoethyl]amino]ethyl]-3-oxanyl]benzamide

C21H30FN3O5 (423.2169382)


   

2-fluoro-N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-[[2-(4-morpholinyl)-1-oxoethyl]amino]ethyl]-3-oxanyl]benzamide

2-fluoro-N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-[[2-(4-morpholinyl)-1-oxoethyl]amino]ethyl]-3-oxanyl]benzamide

C21H30FN3O5 (423.2169382)


   

2-fluoro-N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-[[2-(4-morpholinyl)-1-oxoethyl]amino]ethyl]-3-oxanyl]benzamide

2-fluoro-N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-[[2-(4-morpholinyl)-1-oxoethyl]amino]ethyl]-3-oxanyl]benzamide

C21H30FN3O5 (423.2169382)


   

3-[(3aS,4S,9bS)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]-N,N-dimethylbenzamide

3-[(3aS,4S,9bS)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]-N,N-dimethylbenzamide

C24H29N3O4 (423.21579540000005)


   

3-[(3aS,4R,9bS)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]-N,N-dimethylbenzamide

3-[(3aS,4R,9bS)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]-N,N-dimethylbenzamide

C24H29N3O4 (423.21579540000005)


   

(8R,9R,10S)-N-(4-fluorophenyl)-10-(hydroxymethyl)-9-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazabicyclo[6.2.0]decane-6-carboxamide

(8R,9R,10S)-N-(4-fluorophenyl)-10-(hydroxymethyl)-9-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazabicyclo[6.2.0]decane-6-carboxamide

C25H30FN3O2 (423.2321932)


   

(8S,9R,10R)-N-(4-fluorophenyl)-10-(hydroxymethyl)-9-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazabicyclo[6.2.0]decane-6-carboxamide

(8S,9R,10R)-N-(4-fluorophenyl)-10-(hydroxymethyl)-9-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazabicyclo[6.2.0]decane-6-carboxamide

C25H30FN3O2 (423.2321932)


   

(8S,9S,10R)-N-(4-fluorophenyl)-10-(hydroxymethyl)-9-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazabicyclo[6.2.0]decane-6-carboxamide

(8S,9S,10R)-N-(4-fluorophenyl)-10-(hydroxymethyl)-9-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazabicyclo[6.2.0]decane-6-carboxamide

C25H30FN3O2 (423.2321932)


   

(8R,9S,10R)-N-(4-fluorophenyl)-10-(hydroxymethyl)-9-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazabicyclo[6.2.0]decane-6-carboxamide

(8R,9S,10R)-N-(4-fluorophenyl)-10-(hydroxymethyl)-9-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazabicyclo[6.2.0]decane-6-carboxamide

C25H30FN3O2 (423.2321932)


   

(8S,9S,10S)-N-(4-fluorophenyl)-10-(hydroxymethyl)-9-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazabicyclo[6.2.0]decane-6-carboxamide

(8S,9S,10S)-N-(4-fluorophenyl)-10-(hydroxymethyl)-9-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazabicyclo[6.2.0]decane-6-carboxamide

C25H30FN3O2 (423.2321932)


   

cyclopentyl-[(8S,9R,10R)-9-[4-[3-(dimethylamino)prop-1-ynyl]phenyl]-10-(hydroxymethyl)-1,6-diazabicyclo[6.2.0]decan-6-yl]methanone

cyclopentyl-[(8S,9R,10R)-9-[4-[3-(dimethylamino)prop-1-ynyl]phenyl]-10-(hydroxymethyl)-1,6-diazabicyclo[6.2.0]decan-6-yl]methanone

C26H37N3O2 (423.2885622)


   

[(1S)-2-[(4-fluorophenyl)methyl]-7-methoxy-1-methyl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol

[(1S)-2-[(4-fluorophenyl)methyl]-7-methoxy-1-methyl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol

C25H30FN3O2 (423.2321932)


   

(6R,7R,8R)-N-cyclopentyl-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

(6R,7R,8R)-N-cyclopentyl-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C25H33N3O3 (423.2521788)


   

(6S,7R,8S)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-propyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

(6S,7R,8S)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-propyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C25H33N3O3 (423.2521788)


   

(6R,7S,8S)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-propyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

(6R,7S,8S)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-propyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C25H33N3O3 (423.2521788)


   

(6R,7S,8R)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-propyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

(6R,7S,8R)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-propyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C25H33N3O3 (423.2521788)


   

(6S,7R,8R)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-propyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

(6S,7R,8R)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-propyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C25H33N3O3 (423.2521788)


   

(6R,7R,8R)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-propyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

(6R,7R,8R)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-propyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C25H33N3O3 (423.2521788)


   

(2S,3R)-1-(2-cyclopropyl-1-oxoethyl)-N-(2-fluorophenyl)-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptane-6-carboxamide

(2S,3R)-1-(2-cyclopropyl-1-oxoethyl)-N-(2-fluorophenyl)-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptane-6-carboxamide

C24H26FN3O3 (423.1958098)


   

(2S,3S)-1-(2-cyclopropyl-1-oxoethyl)-N-(2-fluorophenyl)-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptane-6-carboxamide

(2S,3S)-1-(2-cyclopropyl-1-oxoethyl)-N-(2-fluorophenyl)-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptane-6-carboxamide

C24H26FN3O3 (423.1958098)


   

(2R,3R)-1-(2-cyclopropyl-1-oxoethyl)-N-(2-fluorophenyl)-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptane-6-carboxamide

(2R,3R)-1-(2-cyclopropyl-1-oxoethyl)-N-(2-fluorophenyl)-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptane-6-carboxamide

C24H26FN3O3 (423.1958098)


   

2-cyclopropyl-1-[(1S)-2-(cyclopropylmethyl)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]ethanone

2-cyclopropyl-1-[(1S)-2-(cyclopropylmethyl)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]ethanone

C25H33N3O3 (423.2521788)


   

[(1S)-1-[(2-fluorophenyl)methyl]-7-methoxy-9-methyl-1-spiro[2,3-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol

[(1S)-1-[(2-fluorophenyl)methyl]-7-methoxy-9-methyl-1-spiro[2,3-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol

C25H30FN3O2 (423.2321932)


   

[(1R)-1-[(2-fluorophenyl)methyl]-7-methoxy-9-methyl-1-spiro[2,3-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol

[(1R)-1-[(2-fluorophenyl)methyl]-7-methoxy-9-methyl-1-spiro[2,3-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol

C25H30FN3O2 (423.2321932)


   

(6R,7R,8S)-7-[4-(1-cyclohexenyl)phenyl]-N-cyclopentyl-8-(hydroxymethyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

(6R,7R,8S)-7-[4-(1-cyclohexenyl)phenyl]-N-cyclopentyl-8-(hydroxymethyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C25H33N3O3 (423.2521788)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

2-aminoethyl [2-hydroxy-3-[(Z)-pentadec-9-enoxy]propyl] hydrogen phosphate

2-aminoethyl [2-hydroxy-3-[(Z)-pentadec-9-enoxy]propyl] hydrogen phosphate

C20H42NO6P (423.27496020000007)


   

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (Z)-tetradec-9-enoate

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (Z)-tetradec-9-enoate

C19H38NO7P (423.23857680000003)


   

(2S,3R)-2-(Acetylamino)octadecane-1,3-diol 1-phosphoric acid

(2S,3R)-2-(Acetylamino)octadecane-1,3-diol 1-phosphoric acid

C20H42NO6P (423.27496020000007)


   

cis-5-(6-(1,3-Dioxan-2-YL)hexyl)-trans-4-formyl-2,ref.-3-diphenylisoxazolidine

cis-5-(6-(1,3-Dioxan-2-YL)hexyl)-trans-4-formyl-2,ref.-3-diphenylisoxazolidine

C26H33NO4 (423.2409458000001)


   

(E)-10,16-dichloro-N-(1-hydroxy-3-methoxypropan-2-yl)-N-methylhexadec-4-enamide

(E)-10,16-dichloro-N-(1-hydroxy-3-methoxypropan-2-yl)-N-methylhexadec-4-enamide

C21H39Cl2NO3 (423.2306844)


   

(3E)-3-[1-amino-3-methyl-5-[(E)-2-methyltetradec-4-en-6,8-diynyl]pyrrolidin-2-ylidene]-1,5-dimethylpyrrolidine-2,4-dione

(3E)-3-[1-amino-3-methyl-5-[(E)-2-methyltetradec-4-en-6,8-diynyl]pyrrolidin-2-ylidene]-1,5-dimethylpyrrolidine-2,4-dione

C26H37N3O2 (423.2885622)


   

2-[[(E)-2-acetamido-3-hydroxydodec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E)-2-acetamido-3-hydroxydodec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C19H40N2O6P+ (423.26238500000005)


   

2-[[(E)-2-(butanoylamino)-3-hydroxydec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E)-2-(butanoylamino)-3-hydroxydec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C19H40N2O6P+ (423.26238500000005)


   

2-[hydroxy-[(E)-3-hydroxy-2-(propanoylamino)undec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-(propanoylamino)undec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C19H40N2O6P+ (423.26238500000005)


   

2-[hydroxy-[(E)-3-hydroxy-2-(pentanoylamino)non-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-(pentanoylamino)non-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C19H40N2O6P+ (423.26238500000005)


   

2-[[(E)-2-(hexanoylamino)-3-hydroxyoct-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E)-2-(hexanoylamino)-3-hydroxyoct-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C19H40N2O6P+ (423.26238500000005)


   
   

1-(9Z-tetradecenoyl)-glycero-3-phosphoethanolamine

1-(9Z-tetradecenoyl)-glycero-3-phosphoethanolamine

C19H38NO7P (423.23857680000003)


   

pravastatin(1-)

pravastatin(1-)

C23H35O7 (423.238266)


A monocarboxylic acid anion resulting from the deprotonation of the carboxylic acid group of pravastatin.

   

4-Chloro-alpha-[4-[2-(diethylamino)ethoxy]phenyl]-alpha-phenylbenzeneethanol

4-Chloro-alpha-[4-[2-(diethylamino)ethoxy]phenyl]-alpha-phenylbenzeneethanol

C26H30ClNO2 (423.196495)


   

4,6-dideoxy-4-(2-methoxypropanamido)-3-C-Me-L-Manp2Me-(1->3)-Fucp

4,6-dideoxy-4-(2-methoxypropanamido)-3-C-Me-L-Manp2Me-(1->3)-Fucp

C18H33NO10 (423.2104358)


An amido disaccharide comprising 4,6-dideoxy-4-(2-methoxypropanamido)-3-C-methyl-2-O-methyl-L-mannopyranose linked through the anomeric carbon to the 3-hydroxy group of L-fucose.

   

blasticidin S(1+)

blasticidin S(1+)

C17H27N8O5 (423.2104312)


A guanidinium ion that is the conjugate acid of blasticidin S.

   

beta-anthropyranosyl-(1->3)-alpha-L-rhamnopyranose

beta-anthropyranosyl-(1->3)-alpha-L-rhamnopyranose

C18H33NO10 (423.2104358)


An amino disaccharide consisting of alpha-L-rhamnopyranose having a beta-anthropyranosyl residue attached at the 3-position.

   

LPC(12:1)

LPC(12:1(1))

C20H42NO6P (423.27496020000007)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   
   
   
   
   
   

FAUC 346

FAUC 346

C24H29N3O2S (423.19803740000003)


FAUC 346, a highly selective D3 partial agonist (EC50 = 1.5 nM)[1][2].

   

(4e,7s)-n-[(2e)-3-chloro-2-[(5s)-2,5-dimethyl-6-oxocyclohex-1-en-1-yl]prop-2-en-1-yl]-7-methoxydodec-4-enimidic acid

(4e,7s)-n-[(2e)-3-chloro-2-[(5s)-2,5-dimethyl-6-oxocyclohex-1-en-1-yl]prop-2-en-1-yl]-7-methoxydodec-4-enimidic acid

C24H38ClNO3 (423.25400680000007)


   

(9s,15r,17s)-6-hydroxy-5-methoxy-2,18-dioxa-10-azapentacyclo[20.2.2.1⁹,¹⁷.0³,⁸.0¹⁰,¹⁵]heptacosa-1(24),3(8),4,6,22,25-hexaen-19-one

(9s,15r,17s)-6-hydroxy-5-methoxy-2,18-dioxa-10-azapentacyclo[20.2.2.1⁹,¹⁷.0³,⁸.0¹⁰,¹⁵]heptacosa-1(24),3(8),4,6,22,25-hexaen-19-one

C25H29NO5 (423.20456240000004)


   

(10s,13s)-5-[(3r)-3,7-dimethylocta-1,6-dien-3-yl]-13-(hydroxymethyl)-10-isopropyl-3,9,12-triazatricyclo[6.6.1.0⁴,¹⁵]pentadeca-1,4,6,8(15),11-pentaen-11-ol

(10s,13s)-5-[(3r)-3,7-dimethylocta-1,6-dien-3-yl]-13-(hydroxymethyl)-10-isopropyl-3,9,12-triazatricyclo[6.6.1.0⁴,¹⁵]pentadeca-1,4,6,8(15),11-pentaen-11-ol

C26H37N3O2 (423.2885622)


   

(20r)-4,5,6,10,11-pentamethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaene

(20r)-4,5,6,10,11-pentamethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaene

C25H29NO5 (423.20456240000004)


   

(3'r,3'as,6's,6as,6bs,7'ar,9r,11as,11br)-3',6',10,11b-tetramethyl-2,3'a,4',5,5',6,6',6a,6b,7,7',7'a,8,11a-tetradecahydro-1h,3'h-spiro[cyclohexa[a]fluorene-9,2'-furo[3,2-b]pyridine]-3,11-dione

(3'r,3'as,6's,6as,6bs,7'ar,9r,11as,11br)-3',6',10,11b-tetramethyl-2,3'a,4',5,5',6,6',6a,6b,7,7',7'a,8,11a-tetradecahydro-1h,3'h-spiro[cyclohexa[a]fluorene-9,2'-furo[3,2-b]pyridine]-3,11-dione

C27H37NO3 (423.27732920000005)


   

6-hydroxy-9-(2-methylbut-3-en-2-yl)-4-(2-methylpropyl)-16-propanoyl-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

6-hydroxy-9-(2-methylbut-3-en-2-yl)-4-(2-methylpropyl)-16-propanoyl-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

C25H33N3O3 (423.2521788)


   

(1s,2s,3s,4s,5r,6r,8s,9r,10s,13s,16r,17r)-11-ethyl-6-methoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,8,9,16-tetrol

(1s,2s,3s,4s,5r,6r,8s,9r,10s,13s,16r,17r)-11-ethyl-6-methoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,8,9,16-tetrol

C23H37NO6 (423.26207420000003)


   

(1s,2r,3r,4r,5s,6s,8r,9r,10r,13s,16r,17r,18s)-11-ethyl-6-methoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,8,16,18-tetrol

(1s,2r,3r,4r,5s,6s,8r,9r,10r,13s,16r,17r,18s)-11-ethyl-6-methoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,8,16,18-tetrol

C23H37NO6 (423.26207420000003)


   

(1s,17s,19r)-4,9-dihydroxy-5-methoxy-16-oxa-24-azapentacyclo[15.7.1.1⁸,¹².0²,⁷.0¹⁹,²⁴]hexacosa-2(7),3,5,8(26),9,11-hexaen-15-one

(1s,17s,19r)-4,9-dihydroxy-5-methoxy-16-oxa-24-azapentacyclo[15.7.1.1⁸,¹².0²,⁷.0¹⁹,²⁴]hexacosa-2(7),3,5,8(26),9,11-hexaen-15-one

C25H29NO5 (423.20456240000004)


   

(1s,4s,6s,8s,9r,10r,13s,16s,17r,18s)-11-ethyl-13-(hydroxymethyl)-6,18-dimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,8,16-triol

(1s,4s,6s,8s,9r,10r,13s,16s,17r,18s)-11-ethyl-13-(hydroxymethyl)-6,18-dimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,8,16-triol

C23H37NO6 (423.26207420000003)


   

(1s,2s,4s,6s,9s,10s,11r,13s,15s,16r,17r,18r,19s)-8-ethyl-13,19-dimethoxy-5-oxa-8-azaheptacyclo[8.7.2.1¹⁴,¹⁷.0¹,⁹.0⁴,⁶.0⁶,¹⁸.0¹¹,¹⁶]icosane-2,10,11,15-tetrol

(1s,2s,4s,6s,9s,10s,11r,13s,15s,16r,17r,18r,19s)-8-ethyl-13,19-dimethoxy-5-oxa-8-azaheptacyclo[8.7.2.1¹⁴,¹⁷.0¹,⁹.0⁴,⁶.0⁶,¹⁸.0¹¹,¹⁶]icosane-2,10,11,15-tetrol

C22H33NO7 (423.22569080000005)


   

6,9-dihydroxy-5-methoxy-16-oxa-24-azapentacyclo[15.7.1.1⁸,¹².0²,⁷.0¹⁹,²⁴]hexacosa-2,4,6,8(26),9,11-hexaen-15-one

6,9-dihydroxy-5-methoxy-16-oxa-24-azapentacyclo[15.7.1.1⁸,¹².0²,⁷.0¹⁹,²⁴]hexacosa-2,4,6,8(26),9,11-hexaen-15-one

C25H29NO5 (423.20456240000004)


   

5-hydroxy-3-[(7-{[3-(hydroxymethyl)-3-methyloxiran-2-yl]methyl}-2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl)methylidene]-6-methyl-1,6-dihydropyrazin-2-one

5-hydroxy-3-[(7-{[3-(hydroxymethyl)-3-methyloxiran-2-yl]methyl}-2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl)methylidene]-6-methyl-1,6-dihydropyrazin-2-one

C24H29N3O4 (423.21579540000005)


   

11-ethyl-13-(hydroxymethyl)-6,16-dimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,8,9-triol

11-ethyl-13-(hydroxymethyl)-6,16-dimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,8,9-triol

C23H37NO6 (423.26207420000003)


   

(2s,4r,9as)-4-(3-hydroxy-4-methoxyphenyl)-octahydro-1h-quinolizin-2-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

(2s,4r,9as)-4-(3-hydroxy-4-methoxyphenyl)-octahydro-1h-quinolizin-2-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

C25H29NO5 (423.20456240000004)


   

(3z,5z,7z,11z,13z,15z,17z)-20-[(2e)-hex-2-en-1-yl]-7,15-dimethyl-1-azacycloicosa-1,3,5,7,11,13,15,17-octaene-2,9,10-triol

(3z,5z,7z,11z,13z,15z,17z)-20-[(2e)-hex-2-en-1-yl]-7,15-dimethyl-1-azacycloicosa-1,3,5,7,11,13,15,17-octaene-2,9,10-triol

C27H37NO3 (423.27732920000005)